146 related articles for article (PubMed ID: 35649682)
41. Aberrant C-terminal domain of polymerase η targets the functional enzyme to the proteosomal degradation pathway.
Ahmed-Seghir S; Pouvelle C; Despras E; Cordonnier A; Sarasin A; Kannouche PL
DNA Repair (Amst); 2015 May; 29():154-65. PubMed ID: 25766642
[TBL] [Abstract][Full Text] [Related]
42. The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.
Dyson OF; Pagano JS; Whitehurst CB
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724765
[TBL] [Abstract][Full Text] [Related]
43. Molecular genetics of Xeroderma pigmentosum variant.
Gratchev A; Strein P; Utikal J; Sergij G
Exp Dermatol; 2003 Oct; 12(5):529-36. PubMed ID: 14705792
[TBL] [Abstract][Full Text] [Related]
44. Mutational signatures and increased retrotransposon insertions in xeroderma pigmentosum variant skin tumors.
Corradi C; Vilar JB; Buzatto VC; de Souza TA; Castro LP; Munford V; De Vecchi R; Galante PAF; Orpinelli F; Miller TLA; Buzzo JL; Sotto MN; Saldiva P; de Oliveira JW; Chaibub SCW; Sarasin A; Menck CFM
Carcinogenesis; 2023 Aug; 44(6):511-524. PubMed ID: 37195263
[TBL] [Abstract][Full Text] [Related]
45. Diverse roles of RAD18 and Y-family DNA polymerases in tumorigenesis.
Yang Y; Gao Y; Zlatanou A; Tateishi S; Yurchenko V; Rogozin IB; Vaziri C
Cell Cycle; 2018; 17(7):833-843. PubMed ID: 29683380
[TBL] [Abstract][Full Text] [Related]
46. Xeroderma pigmentosum-variant patients from America, Europe, and Asia.
Inui H; Oh KS; Nadem C; Ueda T; Khan SG; Metin A; Gozukara E; Emmert S; Slor H; Busch DB; Baker CC; DiGiovanna JJ; Tamura D; Seitz CS; Gratchev A; Wu WH; Chung KY; Chung HJ; Azizi E; Woodgate R; Schneider TD; Kraemer KH
J Invest Dermatol; 2008 Aug; 128(8):2055-68. PubMed ID: 18368133
[TBL] [Abstract][Full Text] [Related]
47. DNA binding properties of human DNA polymerase eta: implications for fidelity and polymerase switching of translesion synthesis.
Kusumoto R; Masutani C; Shimmyo S; Iwai S; Hanaoka F
Genes Cells; 2004 Dec; 9(12):1139-50. PubMed ID: 15569147
[TBL] [Abstract][Full Text] [Related]
48. Requirement for functional DNA polymerase eta in genome-wide repair of UV-induced DNA damage during S phase.
Auclair Y; Rouget R; Belisle JM; Costantino S; Drobetsky EA
DNA Repair (Amst); 2010 Jul; 9(7):754-64. PubMed ID: 20457011
[TBL] [Abstract][Full Text] [Related]
49. Human DNA polymerase eta is required for common fragile site stability during unperturbed DNA replication.
Rey L; Sidorova JM; Puget N; Boudsocq F; Biard DS; Monnat RJ; Cazaux C; Hoffmann JS
Mol Cell Biol; 2009 Jun; 29(12):3344-54. PubMed ID: 19380493
[TBL] [Abstract][Full Text] [Related]
50. [Advances of study on human translesion synthesis DNA polymerase eta].
Hu GH; Zhuang ZX
Wei Sheng Yan Jiu; 2006 Nov; 35(6):808-11. PubMed ID: 17290774
[TBL] [Abstract][Full Text] [Related]
51. Overproduction of DNA polymerase eta does not raise the spontaneous mutation rate in diploid human fibroblasts.
King NM; Nikolaishvili-Feinberg N; Bryant MF; Luche DD; Heffernan TP; Simpson DA; Hanaoka F; Kaufmann WK; Cordeiro-Stone M
DNA Repair (Amst); 2005 Jun; 4(6):714-24. PubMed ID: 15886068
[TBL] [Abstract][Full Text] [Related]
52. Homologous recombination mediates S-phase-dependent radioresistance in cells deficient in DNA polymerase eta.
Nicolay NH; Carter R; Hatch SB; Schultz N; Prevo R; McKenna WG; Helleday T; Sharma RA
Carcinogenesis; 2012 Nov; 33(11):2026-34. PubMed ID: 22822095
[TBL] [Abstract][Full Text] [Related]
53. Participation of mouse DNA polymerase iota in strand-biased mutagenic bypass of UV photoproducts and suppression of skin cancer.
Dumstorf CA; Clark AB; Lin Q; Kissling GE; Yuan T; Kucherlapati R; McGregor WG; Kunkel TA
Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18083-8. PubMed ID: 17114294
[TBL] [Abstract][Full Text] [Related]
54. Mutagenic Bypass of an Oxidized Abasic Lesion-Induced DNA Interstrand Cross-Link Analogue by Human Translesion Synthesis DNA Polymerases.
Xu W; Ouellette A; Ghosh S; O'Neill TC; Greenberg MM; Zhao L
Biochemistry; 2015 Dec; 54(50):7409-22. PubMed ID: 26626537
[TBL] [Abstract][Full Text] [Related]
55. ATR/Chk1 pathway is essential for resumption of DNA synthesis and cell survival in UV-irradiated XP variant cells.
Despras E; Daboussi F; Hyrien O; Marheineke K; Kannouche PL
Hum Mol Genet; 2010 May; 19(9):1690-701. PubMed ID: 20123862
[TBL] [Abstract][Full Text] [Related]
56. The active site residues Gln55 and Arg73 play a key role in DNA damage bypass by S. cerevisiae Pol η.
Boldinova EO; Ignatov A; Kulbachinskiy A; Makarova AV
Sci Rep; 2018 Jul; 8(1):10314. PubMed ID: 29985422
[TBL] [Abstract][Full Text] [Related]
57. PDIP38/PolDIP2 controls the DNA damage tolerance pathways by increasing the relative usage of translesion DNA synthesis over template switching.
Tsuda M; Ogawa S; Ooka M; Kobayashi K; Hirota K; Wakasugi M; Matsunaga T; Sakuma T; Yamamoto T; Chikuma S; Sasanuma H; Debatisse M; Doherty AJ; Fuchs RP; Takeda S
PLoS One; 2019; 14(3):e0213383. PubMed ID: 30840704
[TBL] [Abstract][Full Text] [Related]
58. Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients.
Broughton BC; Cordonnier A; Kleijer WJ; Jaspers NG; Fawcett H; Raams A; Garritsen VH; Stary A; Avril MF; Boudsocq F; Masutani C; Hanaoka F; Fuchs RP; Sarasin A; Lehmann AR
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):815-20. PubMed ID: 11773631
[TBL] [Abstract][Full Text] [Related]
59. DNA polymerase zeta cooperates with polymerases kappa and iota in translesion DNA synthesis across pyrimidine photodimers in cells from XPV patients.
Ziv O; Geacintov N; Nakajima S; Yasui A; Livneh Z
Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11552-7. PubMed ID: 19564618
[TBL] [Abstract][Full Text] [Related]
60. Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity.
Masutani C; Araki M; Yamada A; Kusumoto R; Nogimori T; Maekawa T; Iwai S; Hanaoka F
EMBO J; 1999 Jun; 18(12):3491-501. PubMed ID: 10369688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
